Venetoclax Plus Azacitidine, Low Dose Cytarabine, Aclarubicin and G-CSF (VA-CAG Regimen) for Newly Diagnosed Young Patients with Acute Myeloid Leukemia: A Prospective, Multicenter, SingleArm Phase 2 Clinical Trial

被引：0

作者：

Li, Xiaoping ^{[1
]}

Li, Xiaoyan ^{[2
]}

Jin, Yanling ^{[3
]}

Chen, Zucong ^{[4
]}

Shen, Yonglin ^{[5
]}

Yuan, Zhongtao ^{[1
]}

Liu, Lin ^{[1
]}

Li, Yu ^{[1
]}

Luo, Le ^{[1
]}

Hou, Shiqian ^{[6
]}

Zhou, Chaoyang ^{[7
]}

Qiu, Chie ^{[8
]}

Zhang, Kui ^{[9
]}

Li, Chunfu ^{[10
,11
]}

Liang, Yang ^{[12
]}

Sanbin, Wang, Sr. ^{[1
]}

机构：

[1] 920th Hosp Joint Logist Support Force, Dept Hematol, Kunming, Yunnan, Peoples R China

[2] First Peoples Hosp Baoshan, Baoshan, Peoples R China

[3] First Peoples Hosp Qujing, Qujing, Peoples R China

[4] Dehong Peoples Hosp, Dehong, Peoples R China

[5] Peoples Hosp Honghe, Honghe, Peoples R China

[6] Peoples Hosp Yuxi, Yuxi, Peoples R China

[7] Peoples Hosp Chuxiong, Chuxiong, Peoples R China

[8] Northeast Cent Hosp Yunnan Prov, Zhaotong, Peoples R China

[9] Second Peoples Hosp Qujing, Qujing, Peoples R China

[10] Nanfang Hosp, Guangzhou, Peoples R China

[11] Nanfang Chunfu Childrens Inst Hematol & Oncol, Dongguan, Peoples R China

[12] Yale Univ, Sch Med, Yale Canc Ctr, Guangzhou, Guangdong, Peoples R China

来源：

BLOOD | 2023年 / 142卷

关键词：

D O I：

10.1182/blood-2023-174469

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页数：3

共 50 条

[1] Venetoclax plus D-CAG (decitabine, cytarabine, aclarubicin, G-CSF) for elderly or unfit patients with newly diagnosed acute myeloid leukemia: a multicenter, prospective study
Ma, Hongbing
Du, Yiwen
Li, Jianjun
Rao, Jin
Guo, Yong
Yang, Yunfan
Zhang, Duanzhong
Wang, Jia
Liao, Yi
Gong, Yuping
ANNALS OF HEMATOLOGY, 2024, : 5315 - 5323
[2] Comparison of Safety and Efficacy between Venetoclax Combined with CAG (cytarabine, aclarubicin, G-CSF) Regimen and CAG Regimen Alone in Patients with Relapsed or Refractory Acute Myeloid Leukemia
Yu, Wen-Jing
Wu, Ying
Chen, Qi
Zhu, Xiaolu
Pei, Xu-Ying
Jia, Jin-Song
Wang, Jing
Zhao, Xiao-Su
Chang, Ying-Jun
Lai, Yue-Yun
Shi, Hong-Xia
Ruan, Guo-Rui
Qin, Ya-Zhen
Liu, Xiao-Hong
Huang, Xiao Jun
Jiang, Hao
BLOOD, 2023, 142
[3] EFFICACY AND SAFETY OF ETOPOSIDE IN COMBINATION WITH G-CSF, LOW-DOSE CYTARABINE AND ACLARUBICIN IN NEWLY DIAGNOSED ELDERLY PATIENTS WITH ACUTE MYELOID LEUKEMIA
Gao, L.
Feng, Y. M.
Yan, H. J.
Zhang, Y. Q.
Zhang, C.
Gao, L.
Kong, P. Y.
Liu, Y.
Zhu, L. D.
Zeng, Y. J.
Rao, J.
Su, Y.
Yang, T. H.
Wang, S. B.
Li, H. M.
Lou, S. F.
Zhang, X.
HAEMATOLOGICA, 2016, 101 : 387 - 387
[4] Efficacy and safety of decitabine in combination with G-CSF, low-dose cytarabine and aclarubicin in newly diagnosed elderly patients with acute myeloid leukemia
Li, Jianyong
Chen, Yaoyu
Zhu, Yu
Zhou, Jianfeng
Xu, Yanli
Li, Yan
Yu, Kang
Pan, Ling
Wang, Jianmin
Ding, Jiahua
Gu, Jian
Zhou, Shanhua
Shi, Jinning
Hong, Ming
Xu, Ji
Pan, Liangqin
Duan, Limin
Zhang, Run
Zhang, Sujiang
Zhu, Huayuan
Lu, Hua
Liu, Peng
Qiu, Hongxia
Wu, Hanxin
Qian, Sixuan
ONCOTARGET, 2015, 6 (08) : 6448 - 6458
[5] Efficacy and safety of decitabine combined with HAAG (homoharringtonine, aclarubicin, low-dose cytarabine and G-CSF) for newly diagnosed acute myeloid leukemia
Zhu, Jun-Feng
Dai, Hai-Ping
Zhang, Qian-Qian
Yin, Jia
Li, Zheng
Cui, Qin-Ya
Tian, Xiao-Peng
Liu, Si-Ning
Jin, Zheng-Ming
Zhu, Xia-Ming
Wu, De-Pei
Tang, Xiao-Wen
FRONTIERS IN ONCOLOGY, 2022, 12
[6] A meta-analysis of CAG (cytarabine, aclarubicin, G-CSF) regimen for the treatment of 1029 patients with acute myeloid leukemia and myelodysplastic syndrome
Wei, Guoqing
Ni, Wanmao
Chiao, Jen-wei
Cai, Zhen
Huang, He
Liu, Delong
JOURNAL OF HEMATOLOGY & ONCOLOGY, 2011, 4
[7] A meta-analysis of CAG (cytarabine, aclarubicin, G-CSF) regimen for the treatment of 1029 patients with acute myeloid leukemia and myelodysplastic syndrome
Guoqing Wei
Wanmao Ni
Jen-wei Chiao
Zhen Cai
He Huang
Delong Liu
Journal of Hematology & Oncology, 4
[8] Etoposide in combination with low-dose CAG (cytarabine, aclarubicin, G-CSF) for the treatment of relapsed or refractory acute myeloid leukemia: A multicenter, randomized control trial in southwest China
Zhang, Xi
Li, Yunlong
Zhang, Yanqi
Chen, Xinghua
Zhang, Cheng
Gao, Li
Kong, Peiyan
Liu, Yao
Wen, Qin
Zeng, Yunjing
Wang, Qingyu
Su, Yi
Wang, Chunsen
Wang, Sanbin
Yuan, Zhong
Gao, Lei
LEUKEMIA RESEARCH, 2013, 37 (06) : 657 - 664
[9] Aclarubicin, Low-Dose Cytarabine Combined With G-CSF (CAG) Regimen For Patients Previously Treated Or Ineligible For Intensive Chemotherapy With Acute Myeloid Leukemia and Myelodysplastic Syndrom: A Single Center Experience
Minauchi, Koichiro
Obara, Masato
Ara, Takahide
Shima, Kanako
Yasumoto, Atsushi
Nakata, Masanobu
Ota, Shuichi
Imai, Kiyotoshi
Hirano, Teiichi
Kiyama, Yoshio
Ogasawara, Masahiro
Kobayashi, Naoki
Imamura, Masahiro
BLOOD, 2013, 122 (21)
[10] Phase 2 study of chidamide in combination with CAG and venetoclax-azacitidine in older patients with newly diagnosed acute myeloid leukemia
Liu, Qingyang
Yang, Jingjing
Lv, Lei
Zhang, Xiawei
Li, Meng
Xu, Lingmin
Huang, Sai
Jing, Yu
Dou, Liping
FRONTIERS IN IMMUNOLOGY, 2025, 16

← 1 2 3 4 5 →